Compare VCEL & BPOPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | BPOPM |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | N/A |
| IPO Year | 1996 | N/A |
| Metric | VCEL | BPOPM |
|---|---|---|
| Price | $31.43 | $25.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $58.50 | N/A |
| AVG Volume (30 Days) | ★ 516.8K | 1.5K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.09 | N/A |
| Revenue Next Year | $17.96 | N/A |
| P/E Ratio | $102.38 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $29.24 | $24.54 |
| 52 Week High | $48.75 | $25.98 |
| Indicator | VCEL | BPOPM |
|---|---|---|
| Relative Strength Index (RSI) | 32.65 | 49.77 |
| Support Level | $31.24 | $25.25 |
| Resistance Level | $38.15 | $25.40 |
| Average True Range (ATR) | 1.22 | 0.02 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 4.94 | 41.35 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Popular Capital Trust II is a statutory trust. It is engaged in issuing capital securities.